Dr. Andrew Eisenberger, MD

Dr. Eisenberger practices at Columbia University Irving Medical Center in New York, New York.

Dr. Eisenberger's NPI, 1962528794, was assigned on March 22, 2007. Dr. Eisenberger graduated from Albert Einstein College of Medicine in 2001. Dr. Eisenberger holds New York license 230949.

Dr. Eisenberger's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Eisenberger's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Eisenberger is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Eisenberger to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eisenberger practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Eisenberger's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Eisenberger's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease, lung cancer, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Eisenberger treats.

CMS data shows 928 Medicare services from Dr. Eisenberger across 7 procedure codes in 2024, for 355 Medicare patients. Medicare paid $66,738 for them.

CMS counts 355 Medicare patients who saw Dr. Eisenberger in 2024. The largest group is 75 to 84, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eisenberger's median patient age at 65, with 55% women.

In 2024, Dr. Eisenberger wrote 1,080 Medicare Part D claims for 160 patients. 57% of them were for generic drugs. CMS names the drug for 825 of them, across 26 drugs with 11 or more claims each, at $2,249,091 in total drug cost. In 2023, CMS named 821 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Eisenberger for performance year 2024, reported through an alternative payment model (APM). Dr. Eisenberger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eisenberger as offering telehealth.

Dmand AI links 60 papers to Dr. Eisenberger, published from 2008 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Anticoagulants, Blood Coagulation and Venous Thromboembolism. Dr. Eisenberger has published most often in J Clin Invest. Dr. Eisenberger's most frequent co-authors are Koji Takeda, MD, Melana Yuzefpolskaya, MD and Paolo Carlo Colombo, MD.

Dmand AI links Dr. Eisenberger to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral.

CMS Open Payments shows 1 general payment to Dr. Eisenberger from 1 drug or device company in 2024. Education make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $15.

Dmand AI lists 1 award for Dr. Eisenberger.

Dr. Eisenberger graduated from Albert Einstein College of Medicine in 2001.

Dr. Eisenberger is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.